12 episodes

Focal Points is the official podcast of Focalpoint Partners.

Focalpoint Partners is a venture capital fund that catalyzes healthcare breakthroughs by aligning people, technology and capital.

Focal Points Brom Rector and Focalpoint Partners

    • Technology
    • 5.0 • 5 Ratings

Focal Points is the official podcast of Focalpoint Partners.

Focalpoint Partners is a venture capital fund that catalyzes healthcare breakthroughs by aligning people, technology and capital.

    Elliot Marseille - UC Berkeley Healthcare Economist on the Financial Viability of Psychedelic Therapy

    Elliot Marseille - UC Berkeley Healthcare Economist on the Financial Viability of Psychedelic Therapy

    Will MDMA and psychedelic therapy be affordable?

    There are lots of questions about the economic and financial future of psychedelic therapies. How much will they cost? Will insurance cover them? And more fundamentally, how does one even begin to quantify the value of a psychedelic experience?

    Today’s guest, Elliot Marseille, PhD is here to explore all these questions and more.

    Dr. Marseille is a leading expert on the economics of the emerging psychedelic-assisted therapies. He is the founding Director of the UC Berkeley's Global Initiative for Psychedelic Science Economics (GIPSE), a network of health economists and health services researchers dedicated to realizing the potential of psychedelic therapies for high-priority mental health conditions. Through the application of policy-relevant economic analyses, GIPSE seeks to enhance the efficiency of service delivery, and increase access to these promising therapies.

    Follow Dr. Marseille's work: https://cghdde.berkeley.edu/projects/global-initiative-psychedelic-science-economics-gipse

    • 52 min
    Can Kanna Treat Premature Ejaculation? The Plant Medicine Solution for Male Sexual Health with John Boghossian and Dr Ryan Protzko

    Can Kanna Treat Premature Ejaculation? The Plant Medicine Solution for Male Sexual Health with John Boghossian and Dr Ryan Protzko

    Can Kanna, a plant medicine from South Africa treat premature ejaculation? John Boghossian and Dr Ryan Protzko from Kanna Health are here to educate us.



    https://www.kanna.health/

    • 1 hr
    Can Skull Implants Treat Depression? Jacob Robinson & Motif Neurotech (Crossover Episode on Business Trip)

    Can Skull Implants Treat Depression? Jacob Robinson & Motif Neurotech (Crossover Episode on Business Trip)

    Can brain implants treat your depression? Ok, technically this would be a skull implant, not a brain implant - but still!



    Jacob Robinson from Motif Neurotech discusses the future of minimally invasive electronic medicine from mental health and beyond.



    This is a crossover episode from the Business Trip podcast.

    • 55 min
    How Life Science VCs do Due Diligence on Potential Investments - Sam Tabone, Focalpoint Partners

    How Life Science VCs do Due Diligence on Potential Investments - Sam Tabone, Focalpoint Partners

    Today’s guest is Samantha Tabone.  Sam is a Partner at Focalpoint where she leads in-depth technical and scientific due diligence on Empath’s psychedelic biotech investments.  Sam is here to help break down the due diligence process Empath uses when evaluating potential investments in psychedelic biotech companies.  Empath's Due Diligence process is broken down into 4 pillars:  Team, Intellectual Property, Scientific Foundations and Operations / Strategy.  



    Prior to Focalpoint, Sam served as the VP of R&D for PurMinds, a neuromedicine startup developing novel therapeutics for neurodegenerative diseases.  As an independent consultant she’s led projects for leading psychedelic companies including Beckley Psytech, advised family offices on Life Science investment strategies, and worked as a temporary strategic director at several biotech startups.  Sam has been fascinated with neuroscience and psychedelics (especially DMT) since she was in her teens.  She’s most excited about funding psychedelic startups working towards solutions for complex neurological disorders.  She holds a B.S. in Chemistry from the University of Toronto and attended the University of Wisconsin-Madison’s Pharmaceutical Sciences Master’s program.  

    • 1 hr 58 min
    Zach Haigney, Author of The Trip Report - Future Trends in Psychedelic Medicine

    Zach Haigney, Author of The Trip Report - Future Trends in Psychedelic Medicine

    Zach Haigney is the author of The Trip Report, a newsIetter that covers the emerging psychedelic science, medicine, and policy landscape.  In this conversation, Zach and Brom discuss emerging trends, questions and hot topics in the psychedelics industry including:  


    The lines of tension between Drug Development and Drug Policy
    Directive vs Non-Directive Psychedelic Therapy 
    How Psychedelics are inverting the traditional drug development model 
    What business models will emerge in psychedelics? 
    Are fears about VC investment in psychedelics overstated?  
    How psychedelics can be thought of as a form of hormetic therapy 
    What can psychedelics be used for outside of treating mental health issues?  



    We also discuss The Trip Report's recent acquisition by Beckley Waves.  

    You can check out The Trip Report here:  https://thetripreport.substack.com/ 

    Follow Zach on Twitter: https://twitter.com/zach_haigney

    Follow Brom on Twitter:  https://twitter.com/therealbrom 



    Make sure to subscribe to the show!

    • 58 min
    Sam Banister - The Art and Science of Designing Novel Psychoactive Therapeutics

    Sam Banister - The Art and Science of Designing Novel Psychoactive Therapeutics

    Sam Banister is a medicinal chemist and co-founder of Psylo.  Psylo is an Australian psychedelic biotech company using machine learning assisted drug design techniques to developing novel psychedelic medicines to treat mental illness.   



    Sam is here to help us understand how new chemical entities are reshaping the psychedelic field; how novel psychedelic molecules are made,  and how new chemical entities are going to play a dominant role in the future of psychedelic medicine.  



    Make sure to subscribe to the show!  



    Follow Brom on twitter: https://twitter.com/therealbrom

    Follow Sam on twitter: https://twitter.com/samuel_b_phd

    Brom's VC Fund:  https://www.empath.vc

    Highlighted Timestamps:  

    06:12 - Are next generation psychedelics taking over in 10 years?  

    16:10 - What is the process like for creating a new chemical entities?  

    50:39 - Psychedelics vs Cannabis: New drug discoveries

    • 1 hr 1 min

Customer Reviews

5.0 out of 5
5 Ratings

5 Ratings

Emery Goossens ,

Professional Analysis, Novel Content

brom provides an insiders view into an up and coming industry with amazing interviews and detailed company analyses. Topics can be quite complex, but he covers them in an approachable way. I’m always excited to see new content from this guy!

Top Podcasts In Technology

Acquired
Ben Gilbert and David Rosenthal
All-In with Chamath, Jason, Sacks & Friedberg
All-In Podcast, LLC
Lex Fridman Podcast
Lex Fridman
Hard Fork
The New York Times
TED Radio Hour
NPR
Darknet Diaries
Jack Rhysider

You Might Also Like

All-In with Chamath, Jason, Sacks & Friedberg
All-In Podcast, LLC
Very Bad Wizards
Tamler Sommers & David Pizarro
Pivot
New York Magazine
The Daily
The New York Times
On Point | Podcast
WBUR
Fresh Air
NPR